BBV152 – Bharat Biotech vs placebo
Systemic reactogenicity events
BBV152 – Bharat Biotech leads to higher systemic reactogenicity eventsg compared with placebo (high certainty).
1 finding from 1 review
- RR 1.34 [1.15, 1.58]2 studies · 25925 participantsHigh